Format

Send to

Choose Destination
Risk Anal. 2017 Jun;37(6):1041-1051. doi: 10.1111/risa.12823. Epub 2017 May 4.

Modeling and Managing the Risks of Measles and Rubella: A Global Perspective Part II.

Author information

1
Kid Risk, Inc., Orlando, FL, USA.
2
University of Central Florida, College of Medicine, Orlando, FL, USA.

Abstract

Measles and rubella continue to circulate globally. Complementing Part I of the special issue, this introduction provides a contrast between other global eradication initiatives and the experience with measles and rubella eradication to date. This introduction builds on the syntheses of the literature provided in Part I and it describes the creation and application of a national risk assessment tool and the development of a dynamic disease transmission model to support global efforts to optimally manage measles and rubella globally using vaccines. Currently, efforts to eradicate measles and rubella suffer from the lack of a commitment to global eradication by key stakeholders, despite strong evidence that their eradication represents a better health and financial option than continued control.

KEYWORDS:

Infectious disease; measles; modeling; rubella

PMID:
28471528
DOI:
10.1111/risa.12823
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center